News
14-day weather forecast for B3.BBC Weather in association with MeteoGroup All times are British Summer Time (Europe/London, GMT+1) unless otherwise stated.
A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results